Our detailed comparative analysis of the transcript-level PTK expression profiles of purified CD138+ malignant plasma cells from newly diagnosed MM patients vs. normal plasma cells showed that ERBB1/EGFR, ERBB3, SRC, and MERTK were significantly overexpressed in MM cells in comparison to normal control plasma cells. The gene discussed is ERBB3; the disease is Miyoshi myopathy.